Get my own profile
Public access
View all96 articles
3 articles
available
not available
Based on funding mandates
Co-authors
- Mikko AiravaaraUniversity of Helsinki, Faculty of Pharmacy, FinlandVerified email at helsinki.fi
- Jennifer BossertNIDA/NIHVerified email at nih.gov
- Yavin ShahamIRP-NIDAVerified email at intra.nida.nih.gov
- antonello bonciGlobal Institutes on AddictionsVerified email at gia.miami
- Susanne BäckSenior Scientist, R&D Therapy Area CNS, Disease Biology - Neurodegeneration, Orion Pharma, TurkuVerified email at orionpharma.com
- Mark HendersonNational Center for Advancing Translational SciencesVerified email at mail.nih.gov
- Julie NecarsulmerUNC Chapel HillVerified email at med.unc.edu
- Maria LindahlSenior researcher, University of HelsinkiVerified email at helsinki.fi
- Mart Saarmaprofessor, University of HelsinkiVerified email at helsinki.fi
- Danielle Guez-BarberChildren's Hospital of PhiladelphiaVerified email at email.chop.edu
- Juan L. GomezNational Institute on Drug AbuseVerified email at nih.gov
- Pyry KoivulaResearch Specialist, University of PennsylvaniaVerified email at mail.med.upenn.edu
- Nathan MarchantAmsterdam UMCVerified email at amsterdamumc.nl
- Mike MichaelidesInvestigator, National Institute on Drug Abuse Intramural Research ProgramVerified email at nih.gov
- James K. SongUniversity of Colorado at BoulderVerified email at aya.yale.edu
- Mark BordenProfessor, University of Colorado BoulderVerified email at colorado.edu
- Carl R. LupicaSenior Investigator, NIHVerified email at mail.nih.gov
- Andrii DomanskyiPrincipal investigator, University of HelsinkiVerified email at helsinki.fi
- Keith W. WhitakerBattelleVerified email at battelle.org
- Jordi BonaventuraUniversitat de BarcelonaVerified email at ub.edu